PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 186 filers reported holding PDL BIOPHARMA INC in Q3 2017. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $948,000 | -8.9% | 322,473 | -15.1% | 0.00% | – |
| Q4 2017 | $1,041,000 | +2114.9% | 379,922 | +2623.7% | 0.00% | – |
| Q3 2017 | $47,000 | -50.5% | 13,949 | +13.9% | 0.00% | – |
| Q4 2014 | $95,000 | -20.2% | 12,252 | -22.8% | 0.00% | – |
| Q3 2014 | $119,000 | -22.7% | 15,871 | -0.2% | 0.00% | – |
| Q2 2014 | $154,000 | +185.2% | 15,904 | +143.5% | 0.00% | – |
| Q1 2014 | $54,000 | +50.0% | 6,531 | +53.3% | 0.00% | – |
| Q4 2013 | $36,000 | -64.0% | 4,260 | -66.1% | 0.00% | – |
| Q3 2013 | $100,000 | +2.0% | 12,565 | -1.3% | 0.00% | – |
| Q2 2013 | $98,000 | – | 12,731 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |